# US 2014/0154805 A1 · Enhancers of induced pluripotent stem cell reprogramming

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0154805 A1
- Document ID: US20140154805A1
- Status: Published application
- Kind: A1
- Application number: 14/054,551
- Filed: 2013-10-15
- Published: 2014-06-05
- Earliest claimed: 2012-12-03
- Assignees: City of Hope
- Applicants: City of Hope
- Inventors: Yanhong Shi; Man Lun Yip; Wendong Li
- Web page: https://patentgrep.com/patent/US20140154805A1

## CPC

- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- C12N 2501/603: Oct-3/4
- C12N 2506/02: from embryonic cells
- C12N 2506/1307: from adult fibroblasts
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Described herein, inter alia, are methods and compositions useful for induced pluripotent stem cell reprogramming.

## Claims

### Claim 1

A method of expressing an Oct4 protein in a cell, the method comprising
(i) contacting a cell with a compound having the formula:
wherein,
X1 is C(R12) or N;
X2 is C(R4) or N;
X3 is C(R5) or N;
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, wherein R2 and R3 are optionally joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; and
(ii) after step (i), allowing said cell to express an Oct4 protein.

### Claim 2

A method of making an induced pluripotent stem cell comprising:
(i) contacting a non-pluripotent cell with a compound having the formula:
wherein,
X1 is C(R12) or N;
X2 is C(R4) or N;
X3 is C(R5) or N;
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, wherein R2 and R3 are optionally joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl;
(ii) after step (i), allowing said non-pluripotent cell to divide thereby forming said induced pluripotent stem cell.

### Claim 3 (depends on 2)

The method of claim 2, further comprising, prior to step (ii), transfecting said non-pluripotent cell with a nucleic acid encoding an Oct4 protein or introducing a recombinant Oct4 protein into said non-pluripotent cell.

### Claim 4 (depends on 2)

The method of claim 2, further comprising, prior to step (ii), transfecting said non-pluripotent cell with a nucleic acid encoding a Nanog protein or introducing a recombinant Nanog protein into said non-pluripotent cell.

### Claim 5 (depends on 2)

The method of claim 2, further comprising, prior to step (ii), transfecting said non-pluripotent cell with a nucleic acid encoding a Sox2 protein, introducing a recombinant Sox2 protein into said non-pluripotent cell, or contacting said non-pluripotent cell with a Sox2 expression inducer.

### Claim 6 (depends on 2)

The method of claim 2, further comprising, prior to step (ii), transfecting said non-pluripotent cell with a nucleic acid encoding a cMyc protein, introducing a recombinant cMyc protein into said non-pluripotent cell, or contacting said non-pluripotent cell with a cMyc expression inducer.

### Claim 7 (depends on 2)

The method of claim 2, further comprising, prior to step (ii), transfecting said non-pluripotent cell with a nucleic acid encoding a Lin28 protein, introducing a recombinant Lin28 protein into said non-pluripotent cell, or contacting said non-pluripotent cell with a Lin28 expression inducer.

### Claim 8 (depends on 2)

The method of claim 2, further comprising, prior to step (ii), transfecting said non-pluripotent cell with a nucleic acid encoding a Klf4 protein, introducing a recombinant Klf4 protein into said non-pluripotent cell, or contacting said non-pluripotent cell with a Klf4 expression inducer.

### Claim 9 (depends on 2)

The method of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, or substituted or unsubstituted heterocycloalkyl.

### Claim 10 (depends on 2)

The method of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl.

### Claim 11 (depends on 2)

The method of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted C1 to C10 alkyl, substituted or unsubstituted 2 to 10 membered heteroalkyl or substituted or unsubstituted 3 to 8 membered heterocycloalkyl.

### Claim 12 (depends on 2)

The method of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted C1 to C10 alkyl or substituted or unsubstituted 2 to 10 membered heteroalkyl.

### Claim 13 (depends on 2)

The method of one of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, unsubstituted alkyl, unsubstituted heteroalkyl, or substituted heterocycloalkyl.

### Claim 14 (depends on 2)

The method of one of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, unsubstituted alkyl or unsubstituted heteroalkyl.

### Claim 15 (depends on 2)

The method of one o claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, unsubstituted C1 to C10 alkyl, unsubstituted 2 to 10 membered heteroalkyl, or substituted 3 to 8 membered heterocycloalkyl.

### Claim 16 (depends on 2)

The method of one o claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, unsubstituted C1 to C10 alkyl or unsubstituted 2 to 10 membered heteroalkyl.

### Claim 17 (depends on 2)

The method of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, unsubstituted C1 to C10 alkyl or unsubstituted 2 to 10 membered heteroalkyl.

### Claim 18 (depends on 2)

The method of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —N(CH3)2, unsubstituted C1 to C5 alkyl or unsubstituted C1 to C5 alkoxy.

### Claim 19 (depends on 2)

The method of claim 2, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —N(CH3)2, unsubstituted C1 to C5 alkyl, methoxy, ethoxy or propoxy.

### Claim 20 (depends on 2)

The method of claim 2, wherein the compound is selected from the group consisting of

### Claim 21 (depends on 2)

The method of claim 2, wherein the compound is selected from the group consisting of

### Claim 22 (depends on 2)

The method of claim 2, wherein the compound is selected from the group consisting of

### Claim 23 (depends on 2)

The method of claim 2, wherein the compound is selected from the group consisting of

### Claim 24 (depends on 2)

The method of claim 2, wherein R2 and R3 are joined together to form a substituted or unsubstituted heteroaryl.

### Claim 25 (depends on 2)

The method of claim 2, wherein R2 and R3 are joined together to form a substituted or unsubstituted five-membered heteroaryl.

### Claim 26

A composition comprising:
(i) an Oct4 recombinant protein, a Sox2 recombinant protein, a Nanog recombinant protein, a cMyc recombinant protein, a Lin28 recombinant protein, a Klf4 recombinant protein, a nucleic acid encoding an Oct4 protein, a nucleic acid encoding a Sox2 protein, a nucleic acid encoding a Nanog protein, a nucleic acid encoding a cMyc protein, a nucleic acid encoding a Lin28 protein, a nucleic acid encoding a Klf4 protein, a Sox2 expression inducer, a cMyc expression inducer, a Lin28 expression inducer, or a Klf4 expression inducer; and
(ii) a compound having the formula:
wherein,
X1 is C(R12) or N;
X2 is C(R4) or N;
X3 is C(R5) or N;
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, wherein R2 and R3 are optionally joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl.

### Claim 27

A mixture comprising a cell and a compound having the formula:
wherein,
X1 is C(R12) or N;
X2 is C(R4) or N;
X3 is C(R5) or N;
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are independently selected from hydrogen, halogen, —CN, —NO2, —NH2, —CF3, —CCl3, —OH, —SH, —SO3H, —C(O)OH, —C(O)NH2, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, wherein R2 and R3 are optionally joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl.

### Claim 28 (depends on 27)

The mixture of claim 27 wherein the cell is a non-pluripotent cell.

### Claim 29 (depends on 27)

The mixture of claim 27, further comprising a recombinant Oct4 protein, a recombinant Nanog protein, a recombinant Sox2 protein, a recombinant Lin28 protein, a recombinant Klf4 protein, a recombinant cMyc protein, a Sox2 expression inducer, a Lin28 expression inducer, a Klf4 expression inducer, a cMyc expression inducer, a nucleic acid encoding an Oct4 protein, a nucleic acid encoding a Nanog protein, a nucleic acid encoding a Sox2 protein, a nucleic acid encoding a Lin28 protein, a nucleic acid encoding a Klf4 protein, or a nucleic acid encoding a cMyc protein.
